Literature DB >> 10837019

Tumors arising in DNA mismatch repair-deficient mice show a wide variation in mutation frequency as assessed by a transgenic reporter gene.

A Baross-Francis1, M K Milhausen, S E Andrew, G Jevon, F R Jirik.   

Abstract

We reported previously that thymic lymphomas arising in mice lacking the DNA mismatch repair (MMR) gene, Msh2(-/-), exhibited striking elevations in the mutation frequency of a transgenic lacI reporter gene when compared with normal Msh2(-/-) tissues. To investigate whether hypermutation was a feature of all tumors arising in MMR-deficient mice, lacI transgene mutation frequencies were obtained from several different mouse tumors deficient for PMS2 and/or MSH2. While lacI gene hypermutation was again clearly evident in Msh2 +/- ms2(-/-) and Msh2(-/-)Pms2(-/-) thymic lymphomas, three non-thymic MSH2-deficient tumors failed to show lacI gene mutation frequency elevations when compared with a normal tissue of MMR-deficient mice. The elevated mutation frequencies in the lymphoid tumors, and the finding of multiple clustered mutations in lacI genes rescued from these tumors, suggest that they are possibly generated by a lymphoma-specific hypermutational mechanism.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10837019

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  3 in total

1.  A new mutator phenotype in breast cancer?

Authors:  Johan G de Boer
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-19       Impact factor: 11.205

2.  Genetic instability favoring transversions associated with ErbB2-induced mammary tumorigenesis.

Authors:  Shiquan Liu; Wenjing Liu; John L Jakubczak; Gregory L Erexson; Kenneth R Tindall; Richard Chan; William J Muller; Sankar Adhya; Susan Garges; Glenn Merlino
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

3.  Mismatch repair deficient hematopoietic stem cells are preleukemic stem cells.

Authors:  Yulan Qing; Stanton L Gerson
Journal:  PLoS One       Date:  2017-08-02       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.